Amedisys Receivables 2010-2024 | AMED

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Amedisys receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Amedisys receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$17.3B
DaVita (DVA)	$13.7B
Encompass Health (EHC)	$9.3B
Chemed (CHE)	$8.7B
Elanco Animal Health (ELAN)	$7.2B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$5B
Astrana Health (ASTH)	$2.8B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$2.4B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1B
Atai Life Sciences (ATAI)	$208M
Daxor (DXR)	$45M
ATI Physical Therapy (ATIP)	$25M
MEDIROM Healthcare Technologies (MRM)	$19M
Psychemedics (PMD)	$14M
Ontrak (OTRK)	$10M
Novo Integrated Sciences (NVOS)	$6M
IMAC Holdings (BACK)	$2M